Plasma concentrations of the active metabolite I are approximately fivefold higher than those of erdosteine. After multiple doses (300-mg three-times daily for 8 days), the pharmacokinetics of ...

Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...